Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...
St. Jude researchers identified a protein, voltage-dependent anion channel 2 (VDAC2), that tumors use as a “signal jammer” to prevent cancer cell death and evade the immune system’s functioning.
Daily Wrap on MSN1h
Ukraine tests anti-jammer drones, reshaping battlefield techIn Ukraine, drones equipped with jammer detection systems are being tested, which could significantly influence the war's ...
Fighterbomber, the unofficial Telegram channel of the Russian air force, has claimed the air force’s widely feared KAB or ...
Russia’s Zhitel jammer has been used to disrupt Starlink – but with only limited success. Now, a £12 million truck-mounted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results